200 related articles for article (PubMed ID: 22562654)
21. Interactions between MAP kinase and oestrogen receptor in human breast cancer.
McGlynn LM; Tovey S; Bartlett JM; Doughty J; Cooke TG; Edwards J
Eur J Cancer; 2013 Apr; 49(6):1176-86. PubMed ID: 23265704
[TBL] [Abstract][Full Text] [Related]
22. 17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells.
Pandini G; Genua M; Frasca F; Squatrito S; Vigneri R; Belfiore A
Cancer Res; 2007 Sep; 67(18):8932-41. PubMed ID: 17875736
[TBL] [Abstract][Full Text] [Related]
23. Estrogen- and xenoestrogen-induced ERK signaling in pituitary tumor cells involves estrogen receptor-α interactions with G protein-αi and caveolin I.
Watson CS; Jeng YJ; Hu G; Wozniak A; Bulayeva N; Guptarak J
Steroids; 2012 Apr; 77(5):424-32. PubMed ID: 22230296
[TBL] [Abstract][Full Text] [Related]
24. Estrogen receptor alpha expression in podocytes mediates protection against apoptosis in-vitro and in-vivo.
Kummer S; Jeruschke S; Wegerich LV; Peters A; Lehmann P; Seibt A; Mueller F; Koleganova N; Halbenz E; Schmitt CP; Bettendorf M; Mayatepek E; Gross-Weissmann ML; Oh J
PLoS One; 2011; 6(11):e27457. PubMed ID: 22096576
[TBL] [Abstract][Full Text] [Related]
25. Sodium arsenite inhibited genomic estrogen signaling but induced pERα (Ser118) via MAPK pathway in breast cancer cells.
Nakareangrit W; Thiantanawat A; Visitnonthachai D; Watcharasit P; Satayavivad J
Environ Toxicol; 2016 Sep; 31(9):1133-46. PubMed ID: 25728338
[TBL] [Abstract][Full Text] [Related]
26. Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor.
Tang HY; Lin HY; Zhang S; Davis FB; Davis PJ
Endocrinology; 2004 Jul; 145(7):3265-72. PubMed ID: 15059947
[TBL] [Abstract][Full Text] [Related]
27. Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation.
Martin LA; Farmer I; Johnston SR; Ali S; Marshall C; Dowsett M
J Biol Chem; 2003 Aug; 278(33):30458-68. PubMed ID: 12775708
[TBL] [Abstract][Full Text] [Related]
28. Activation of estrogen receptor α by estradiol and cisplatin induces platinum-resistance in ovarian cancer cells.
Matsumura S; Ohta T; Yamanouchi K; Liu Z; Sudo T; Kojimahara T; Seino M; Narumi M; Tsutsumi S; Takahashi T; Takahashi K; Kurachi H; Nagase S
Cancer Biol Ther; 2017 Sep; 18(9):730-739. PubMed ID: 27689466
[TBL] [Abstract][Full Text] [Related]
29. Cyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEK-ERK (Raf/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase) pathway.
Kim EJ; Juhnn YS
J Biol Chem; 2015 Apr; 290(15):9604-13. PubMed ID: 25713071
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional activation of c-Fos by constitutively active Galpha(16)QL through a STAT1-dependent pathway.
Lo RK; Wong YH
Cell Signal; 2006 Dec; 18(12):2143-53. PubMed ID: 16781847
[TBL] [Abstract][Full Text] [Related]
31. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
[TBL] [Abstract][Full Text] [Related]
32. The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17beta-estradiol on mouse spermatogonial GC-1 cell line.
Sirianni R; Chimento A; Ruggiero C; De Luca A; Lappano R; Andò S; Maggiolini M; Pezzi V
Endocrinology; 2008 Oct; 149(10):5043-51. PubMed ID: 18566133
[TBL] [Abstract][Full Text] [Related]
33. Palmitoylation regulates 17β-estradiol-induced estrogen receptor-α degradation and transcriptional activity.
La Rosa P; Pesiri V; Leclercq G; Marino M; Acconcia F
Mol Endocrinol; 2012 May; 26(5):762-74. PubMed ID: 22446104
[TBL] [Abstract][Full Text] [Related]
34. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
35. Estrogens promote human testicular germ cell cancer through a membrane-mediated activation of extracellular regulated kinase and protein kinase A.
Bouskine A; Nebout M; Mograbi B; Brücker-Davis F; Roger C; Fenichel P
Endocrinology; 2008 Feb; 149(2):565-73. PubMed ID: 18039775
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptor 4 coupled GI protein signaling pathways regulate extracellular signal-regulated kinase phosphorylation and AP-1 activation independent of NFkappaB activation.
Fan H; Peck OM; Tempel GE; Halushka PV; Cook JA
Shock; 2004 Jul; 22(1):57-62. PubMed ID: 15201703
[TBL] [Abstract][Full Text] [Related]
37. Assays for G-protein-coupled receptor signaling using RGS-insensitive Galpha subunits.
Clark MJ; Traynor JR
Methods Enzymol; 2004; 389():155-69. PubMed ID: 15313565
[TBL] [Abstract][Full Text] [Related]
38. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
Filardo EJ; Quinn JA; Frackelton AR; Bland KI
Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
[TBL] [Abstract][Full Text] [Related]
39. Identification of a novel estrogen receptor-alpha variant and its upstream splicing regulator.
Ohshiro K; Mudvari P; Meng QC; Rayala SK; Sahin AA; Fuqua SA; Kumar R
Mol Endocrinol; 2010 May; 24(5):914-22. PubMed ID: 20304996
[TBL] [Abstract][Full Text] [Related]
40. Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src.
Liu H; Qiu J; Li N; Chen T; Cao X
J Biol Chem; 2010 Jul; 285(29):21934-42. PubMed ID: 20460377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]